- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 78
Corporate venturing deal net: 22-26 April 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Apr 26, 2019RosieReality tints $2.2m seed
ETH Zurich spinout RosieReality has attracted $2.2m in seed capital led by Redalpine, with a contribution from existing backer Akatsuki.
Apr 26, 2019Astroscreen corrects $1m
Set up to identify fake news and social media bot accounts, Astroscreen has attracted UCL Technology Fund for its first funding round.
Apr 25, 2019EARDG Photonics looks into funding
UAVC has put capital into newly launched UA spinout EARDG Photonics, which integrates technology licensed from another spinout, TIPD, by the same co-founders.
Apr 25, 2019Velocity fires up equity investments
Four businesses have collected $37,000 in equity funding each from a micro-VC fund established by University of Waterloo’s Velocity unit in support of the Velocity Fund Finals competition.
Apr 24, 2019Cytura sits atop of seed round
Building on KU Leuven and Amsterdam UMC research, Cytura hopes to find small molecule candidates that combat the issue of genomic variability in cancer.
Apr 23, 2019PaverGuide paves over $650,000
Building on UMCP research, PaverGuide supplies a base material for laying paved surfaces made from recycled plastic rather than stone.
Apr 22, 2019Corporate venturing deal net: 15-18 April 2019
Each week the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Apr 18, 2019Confluence Pharmaceuticals collects $200,000
Indiana University Philanthropic Venture Fund has made its tenth investment, putting $200,000 into Confluence Pharmaceuticals.
Apr 17, 2019Imprimed sniffs out $4m investment
Stanford-StartX Fund has supported a $4m round for Imprimed, which is working on precision cancer treatments for dogs.
Apr 17, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


